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Abstract: Having gained momentum in the last decade, the One Health initiative promotes a holistic approach
to address complex global health issues. Before recommending its adoption to stakeholders, however, it is
paramount to first compile quantitative evidence of the benefit of such an approach. The aim of this scoping
review was to identify and summarize primary research that describes monetary and non-monetary outcomes
following adoption of a One Health approach. An extensive literature search yielded a total of 42,167 refer-
ences, of which 85 were included in the final analysis. The top two biotic health issues addressed in these studies
were rabies and malaria; the top abiotic health issue was air pollution. Most studies described collaborations
between human and animal (n = 42), or human and environmental disciplines (n = 41); commonly reported
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interventions included vector control and animal vaccination. Monetary outcomes were commonly expressed
as cost–benefit or cost–utility ratios; non-monetary outcomes were described using disease frequency or disease
burden measurements. The majority of the studies reported positive or partially positive outcomes. This paper
illustrates the variety of health challenges that can be addressed using a One Health approach, and provides
tangible quantitative measures that can be used to evaluate future implementations of the One Health ap-
proach.
Keywords: One Medicine, Transdisciplinarity, Endemic and emerging infectious diseases, Zoonoses,
Non-communicable diseases, Systematic evidence, Scoping review
INTRODUCTION
The One Health (OH) approach is based on the notion that
human, animal, and environmental health are intimately
connected and mutually dependent (Rabinowitz et al. 2008;
Dixon et al. 2014). Consequently, advocates of this move-
ment describe the need for a holistic and transdisciplinary
approach when tackling complex global health issues with
high societal values (American Veterinary Medical Associ-
ation 2008; Greter et al. 2014).
Despite being considered by some as a novel approach,
the concept of OH dates back many centuries (Oura 2014;
Woods and Bresalier 2014). Several key figures have played
an important role in the promotion of this approach,
through recognition of the similarities between human and
veterinary medical science, the study of zoonoses and
vaccine discovery, and the coining of the terms ‘‘One
Medicine,’’ ‘‘One Health,’’ and ‘‘Ecohealth’’ (Day 2010;
Zinsstag et al. 2011; Murray et al. 2014; Roberts 2014;
Woods and Bresalier 2014). More recent key events in the
OH movement include the publication of the Manhattan
Principles recognizing the importance of a holistic ap-
proach when tackling both epidemic and epizootic diseases
(World Conservation Society 2004) and the signing of the
Tripartite Concept Note which puts onus on promoting
prevention and control of disease at the human–animal–
ecosystem interface (The FAO-OIE-WHO Collaboration
2010).
While the benefits of such a holistic and integrative
movement may seem intuitive, the OH approach has come
under scrutiny for its accountability, particularly since
further investment in such collaborative projects will re-
quire a change in the way funds are allocated (Cleaveland
et al. 2014; Gibbs 2014). Currently, most funds are
administered within sectors. Yet, the collaborative ap-
proaches and applications encouraged by the OH move-
ment often require a substantial initial investment which
may go well beyond the possibilities of independent sectors
or institutions. Therefore, to allow for more researchers to
embrace this approach, there is a need to create inter-
ministerial platforms which allow for more integrated
surveillance and disease control programs involving the
animal, human, and environmental sectors, or novel
funding mechanisms which will provide and accommodate
for this transdisciplinary approach (Ha¨sler et al. 2012;
Gibbs 2014). For example, to prevent human disease and
mitigate agricultural damages, a solution may lie primarily
with more effective animal vaccination programs, requiring
commitment and cohesion across disciplines. However, for
this paradigm shift to occur, funding agencies and policy-
makers must be provided with more evidence on the added
value and cost-effectiveness of such cross-sectorial ap-
proaches (Hodgson and Darling 2011; Ha¨sler et al. 2012;
The World Bank 2012; Boden et al. 2014).
Therefore, the aim of this scoping review (SR) was (1)
to systematically identify those studies that describe a
quantitative outcome when using a OH approach and (2)
to review and qualitatively summarize the health issues
addressed, the type of OH approaches used, and the nature
and value of the quantitative outcomes described. The
purpose of this study is to create an evidence base of the
types of OH applications, and consequent monetary and
non-monetary outcomes accrued.
METHODS
Research Question, Definitions, and Protocol
This SR was conducted to identify and summarize studies
which describe a quantitative outcome when using a OH
approach to address complex global health challenges. The
study was performed as a joint project among residents of
the European College of Veterinary Public Health. The
population of interest within the studies was defined as the
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human and animal population worldwide. The interven-
tion of interest was the ‘‘OH approach,’’ defined as ‘‘the
collaborative efforts of multiple disciplines working locally,
nationally and globally to attain optimal health for people,
animals and our environment’’ (American Veterinary
Medical Association 2008). The outcome of interest was a
‘‘quantitative outcome,’’ measured either in monetary or
non-monetary terms (Rusthon 2009; Rushton et al. 2012;
Minutes of the expert workshop 2013).
An a priori protocol was developed to define eligibility
criteria and procedure after consultation with experts in
OH and veterinary economics. Additional references were
used to help structure the SR (Higgins and Green 2008;
Centre for reviews and dissemination 2009), which is re-
ported according to PRISMA guidelines (Moher et al.
2009). Screening tools (S1 and S2) were pretested before
implementation to ensure clarity of questions.
Literature Search Strategy
The outline of the methodological activities undertaken is
presented in Fig. 1. The search terms presented in Table 1
were used to systematically search four electronic databases:
MEDLINE, CAB Abstracts, Embase, and the National
Health Service Economic Evaluation Database (NHS EED;
UK). The final search was performed on June 5, 2014, and
the search strategies used for each database are presented in
S3–S6. In addition to the electronic search, a search veri-
fication was performed through expert elicitation to help
with the identification of relevant studies within the gray
literature, and by manually searching references in recent
reviews on the topic (Zinsstag et al. 2007; Zinsstag et al.
2011; Ha¨sler et al. 2012; Min et al. 2013).
Study Inclusion Criteria and Screening
The predetermined criteria for a publication to be eligible
for inclusion are given in S1, while the screening strategy
followed is shown in Fig. 1. A publication was considered
eligible for inclusion if it reported primary research on a
quantitative outcome when using a OH approach, even if
not explicitly defined as such, to address complex global
health challenges, and was published after 1910. This date
was selected based on the setup of the databases, whereby
the earliest publication date available was 1910. Primary
research was defined as a study where the author(s) col-
lected and/or analyzed data, and included case reports and
case series, qualitative studies, observational studies, and
experimental studies. Mathematical models and economic
studies were included if they were based on field data
collected in the same study or elsewhere. References were
included if they were in English, German, Italian, Spanish,
French, Portuguese, Greek, Dutch, Finnish, Russian, Nor-
wegian, or Swedish; references in other languages were
excluded. If no abstract was available, and the title was not
sufficiently clear, the publication was included for full-text
screening. Discrepancies regarding a publication’s eligibility
were first resolved among the smaller group of reviewers
and, when necessary, through an online discussion with all
reviewers involved in this study.
Qualitative Data Extraction and Analysis
Data extracted from the included publications are shown in
S7-S12; these included: (1) bibliographic information and
study design characteristics, (2) how the reference was
identified, (3) the health issue addressed, (4) the intersec-
toral approach used (i.e., human–animal vs. human–envi-
ronment vs. animal–environment vs. human–animal–
environment), (5) the quantitative outcome described, and
(6) a quality assessment based on the clarity of the meth-
ods. All extracted data were checked for consistency by two
of the authors (LCF and MLB), and any disagreements were
resolved through discussion between all reviewers.
To allow for further exploration and description of the
studies, the following parameters were extracted: (1) con-
tinent where the study was performed; (2) whether the
country was considered developed or developing, and its
income status; (3) whether the disease agent was abiotic or
biotic and, in case of the latter, whether it was a bacterium,
virus, protozoa, helminth, or insect; (4) whether the health
issue was considered a neglected tropical disease (NTD) or
not; and (5) the type of transmission. The definitions of
these parameters are based on references provided in S13.
Descriptive statistics of the study characteristics (e.g., health
issue described, type of intervention, and outcome) were
performed using Stata (version 13, StataCorp LP, College
Station, TX, USA). Due to the heterogeneity of the studies
and topics involved, quantitative meta-analyses were not
undertaken.
This review was approved by the Ethical Review
Committee at the University of Nottingham, UK (Ethics
Approval Number: 1328141209).
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RESULTS
Figure 1 shows the flow of references through the screening
process. Of the 107 studies that were included for quali-
tative synthesis, 4 were excluded because they showed ele-
ments of a OH approach, but multiple steps described the
link between the OH approach and quantitative outcome,
with certain overarching assumptions not explicitly dis-
cussed (S7). Twelve studies were excluded as ‘‘Mixed
Interventions’’ because, while they described both inter-
disciplinary and disciplinary interventions, it was not
possible to determine the quantitative outcome specifically
due to the OH approach (S8). Another six studies that
described a OH approach to address environmental health
issues were classified separately (S9).
The remaining 85 studies fully met our aim and eli-
gibility criteria (S10–S12); of these, 72 were identified
through the electronic search, while 13 were identified
through search verification. The studies were performed in
all five continents, primarily in Europe (n = 23), Asia
(n = 20), and Africa (n = 16). A total of 56 different
bFig. 1. Flow of methodological activities and information through
the different phases of a scoping review on the quantitative outcome
of a One Health approach to address complex global health
challenges, as described by the PRISMA guidelines (Moher et al.
2009). aKeywords reported in Rushton 2009; Ha¨sler et al. 2012;
Minutes of the Expert Workshop 2013. bBased on a recommendation
that three to five databases are considered sufficient (Young et al.
2014). cTexts available between 1980 and 2014. dTexts available
between 1946 and 2014. eTexts available between 1910 and 2014.
fPart of the National Institute for Health Research Centre for Reviews
and Dissemination, UK. gRefworks (ProQuest, LLC, Cambridge
Information Group; Betheseda, MD, USA). hCommunity of Practice
in Ecosystem Approaches to Health—Canada.
Fig. 2. A world map indicating the number of studies conducted in different countries and included in a scoping review on the quantitative
outcome of a One Health approach to address complex global health challenges.
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countries or regions were represented (Fig. 2), most com-
monly the USA (n = 7), China (n = 4), and Tanzania
(n = 4). Thirty-six studies were performed in developed
countries, while another 44 were performed in developing
countries; the remaining 5 studies either did not specify the
country, or were performed in countries (Cambodia and
Puerto Rico) that did not appear within the reference
document used for the classification of developing/devel-
oped status (United Nations 2014; see S13). Similarly, 37,
25, and 14 of these studies were performed in high-, mid-
dle-, and low-income countries, respectively.
The publication date of the included studies ranged
between 1984 and 2014; the majority (n = 70) were pub-
lished after 2000, of which 33 between 2010 and 2014. The
majority of the included references described modeling
studies such as economic analyses (n = 42), mathematical
modeling (n = 12), and risk assessments (n = 4).
Health Issues Addressed
The health issues addressed in the 85 studies were classified
as biotic (n = 69), abiotic (n = 14), or both (n = 2; Figs. 3
and 4).
Among those studies that included a biotic issue, the
top five diseases described were rabies (n = 13), malaria
(n = 11), salmonellosis (n = 7), campylobacteriosis
(n = 6), and dengue (n = 6). Almost half (n = 32) dealt
with a NTD such as rabies, dengue, echinococcosis, and
Chagas disease. Most of the bacterial studies were per-
formed in Europe (n = 14), while most protozoal studies
were performed in Africa (n = 10).
Air pollution was the most common abiotic health
issue addressed (n = 5); other issues included pesticides,
micro-pollutants in water, and exposure to heavy metals in
water or soil. Most of the 14 studies investigating abiotic
health issues were conducted after the year 2000 and were
performed in Asia (n = 7) and Europe (n = 3).
One Health Approach
The majority of these 85 studies either described a collab-
oration between human and animal (n = 42), or between
human and environmental (n = 41) disciplines. Of all
interventions, environmental interventions were the most
commonly described, and these targeted vector control
(n = 26), pollution (n = 8), sanitation and water (n = 8),
Fig. 3. Abiotic and biotic health
issues described, per continent, in
a scoping review on the quanti-
tative outcome of a One Health
approach to address complex
global health challenges.
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or modified environmental spaces to encourage physical
activity (n = 1). More specifically, vector control was
achieved primarily through the use of insecticide-treated
bed nets, control of breeding sites, and habitat restoration.
Pollution and sanitation were largely controlled through
policies and structural changes. Other interventions de-
scribed included vaccination of domestic animals or wild-
life (either singly or in combination with other
interventions; n = 20), best management practices target-
ing primary production (n = 12), treatment (n = 6), inte-
grated surveillance (n = 2), and combined human and
animal physical activity (n = 2).
Quantitative Outcomes
Of the studies included, some described both monetary and
non-monetary outcomes (n = 31), while others described
only monetary (n = 33) or non-monetary (n = 21) out-
comes (S10-S12).
Most monetary outcomes were described as cost–
benefit ratios (n = 26), cost–utility ratios (n = 18), or cost
savings (n = 15). The majority of the studies had positive
(n = 40) or partially positive (n = 18) monetary outcomes
expressed as positive benefit–cost ratios and net present
values, increased cost–utility ratios, or marked cost savings.
Only four of the studies had a negative monetary outcome,
expressed as negative benefit–to–cost ratios or imbalanced
costs.
Among the non-monetary outcomes, measures of
disease frequency were the most commonly reported out-
come (n = 40), followed by measures of disease burden
(n = 15). Other reported outcomes included vaccination
coverage, disease transmission rates, case detection rates,
animal and human productivity traits, weight loss, and
animal welfare scores. Most studies described positive
(n = 43) or partially positive (n = 6) non-monetary out-
comes, such as reduced number of deaths, decreased
prevalence, or increased disability-adjusted life years (DA-
Fig. 4. Abiotic and biotic health issues described in a scoping review on the quantitative outcome of a One Health approach to study complex
health challenges.
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LYs) saved. Three studies reported no significant difference
in outcome between the OH intervention and control
groups.
The quantitative outcomes reported in studies per-
taining to the top five diseases were examined in further
detail (Fig. 5). The majority of the rabies studies included
in this review showed the benefits, in terms of cost savings
or deaths averted, that could be accrued through either dog
or wildlife vaccination campaigns (Table 2). The food-
borne zoonoses’ studies illustrated the potential reduction
in disease primarily via best management practices at the
farm and slaughterhouse level (Tables 3 and 4), while the
vector-borne studies illustrated benefits in terms of the
interventions’ cost-effectiveness or their impact on disease
transmission (Tables 5 and 6).
Quality Assessment
To perform a quality assessment on the included studies,
judgement was made as to whether the methods were
explicitly stated. The majority of the studies (n = 69) were
determined to have clearly explained and reproducible
methods, while six studies lacked certain information and
were therefore considered as partly reproducible. For the
remaining ten studies, the methods were considered insuf-
ficiently described; there were no recognizable similarities
between these studies as they were conducted in different
regions and described different health issues (S7–S12).
DISCUSSION
This study provides an extensive evidence base for research
highlighting the quantitative outcomes, both monetary and
non-monetary, of an OH approach. Moreover, it adds to
recently published reviews (Ha¨sler et al. 2014a; Baum et al.
2017) by also including research that may not have
explicitly included definitions or terminology relating to
‘‘One Health’’ but employed a OH approach. This work is
of substantial importance in relation to decision-making at
the policy or governmental level and provides some proof
that financing OH projects can be beneficial in a number of
ways. Additionally, this review showcases the approaches
used by a number of researchers and organizations that
could be utilized in a number of global economic settings
to improve human and animal health and welfare.
Most of the included studies dealt with biotic health
issues, and the top five diseases were rabies, malaria,
salmonellosis, campylobacteriosis, and dengue; this could
be driven by funding priorities which are often focused on
large global health challenges. Three of these are zoonoses,
while the other two are vector-borne diseases. It is not
Fig. 5. Proportion of studies
that described monetary, non-
monetary, or both outcomes to
assess the top five diseases
included in a scoping review on
the quantitative outcome of a
One Health approach to address
complex global health challenges.
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surprising that zoonoses would be among the most com-
monly addressed OH topics as they are suited for a col-
laborative approach between human and veterinary
medicine, such as through joint human–animal vaccination
programs, integrated surveillance, and increased invest-
ment in cost-effective animal-level interventions with
consequent human health benefits (Roth et al. 2003;
Schelling et al. 2007; Zinsstag et al. 2009; Tschopp et al.
2013, Sta¨rk et al. 2015).
Rabies is a clear example where OH approaches can be
beneficial. Thirteen of the included studies described rabies,
and all investigated vaccination as an option of controlling
rabies in either dogs or wildlife. Most of these studies
showed that those control programs that include vaccina-
tion are often cost-effective over a long time span, ranging
from 4.1 to 11.0 years in the Philippines (Fishbein et al.
1991), 5.9 years in N’Djame´na (Zinsstag et al. 2009), and
6 years in Bhutan (Tenzin and Ward 2012).
Our review also identified several OH interventions
targeting food-borne zoonoses, a growing concern due to
the increased demand for livestock products and conse-
quent intensification and globalization of the food market
(Karesh et al. 2012; Wall 2014). The importance of food
safety for the general public and policy-makers was
emphasized in a recent document by the European Union
Scientific Steering Committee (European Union Scientific
Steering Committee 2015) and was reiterated in the choice
of Food Safety as the topic for the 2015 World Health Day
(Chan 2014). Seven studies described interventions to
control salmonellosis in either poultry or pig production
systems, and considered the effect of these interventions on
the number of human cases and overall costs incurred.
Competitive exclusion (Persson and Jendteg 1992), control
programs (Kangas et al. 2007; Korsgaard et al. 2009), and
management practices such as hot water decontamination
of carcasses (Miller et al. 2005; Goldbach and Alban 2006)
were all found to be economically effective interventions.
Similarly, the other benefits listed for Salmonella and other
food-borne diseases such as Campylobacter could be uti-
lized by policy-makers to keep these diseases to a mini-
mum.
Vector-borne diseases, such as malaria and dengue,
also featured prominently in our list of included studies. All
the malaria studies assessed control programs which in-
cluded vector control, mostly through the use of insecti-
cide-treated bed nets (ITNs). In several African countries,
ITNs (and long-lasting ITNs) proved to be effective in
reducing the disease (Goodman et al. 1999; Riedel et al.
2010), though these benefits were sometimes outweighed
by the costs incurred (Goodman et al. 2001; Pulkki-
Bra¨nnstro¨m et al. 2012). The WHO recommends only
distributing long-lasting ITNs (World Health Organization
2007); the findings in the current study are valuable in
identifying those interventions that are superior to others
Table 1. A List of the Search Terms Used in Four Electronic Databases (MEDLINE, Embase, NHS EED, and CAB Abstracts) to Identify
References that Describe a Quantitative Outcome when Using a One Health Approach to Address Complex Global Health Challenges.
((animal AND human) OR (animals and human) OR (animal AND humans) OR (animals AND humans) OR (human AND envi-
ronment) OR (humans AND environment) OR (animal AND environment) OR (animals AND environment) OR ‘‘animal to human’’
OR ‘‘human to animal’’ OR ‘‘social-ecological’’ OR ‘‘socio-ecological’’ OR ‘‘One Health’’ OR ‘‘Ecohealth’’ OR ‘‘One World’’ OR ‘‘One
Medicine’’ OR (ecosystem AND health) OR (holistic AND health) OR (veterinary AND human medicine) OR interdisciplinary OR
multidisciplinary OR transdisciplinary OR ‘‘cross sector’’ OR ‘‘inter sector’’ OR ‘‘trans sector’’ OR zoonos* OR zoonotic OR ‘‘vet-
erinary public health’’ OR ‘‘VPH’’ OR ‘‘farm to fork’’ OR ‘‘stable to table’’ OR ‘‘value chain’’)
AND
(DALY* OR HALY* OR QALY* OR ‘‘disability adjusted life year’’ OR ‘‘disability adjusted life years’’ OR ‘‘health adjusted life year’’ OR
‘‘health adjusted life years’’ OR ‘‘quality adjusted life year’’ OR ‘‘quality adjusted life years’’ OR ‘‘expected quality adjusted life year’’ OR
‘‘expected quality adjusted life years’’ OR ‘‘opportunity cost’’ OR ‘‘opportunity costs’’ OR ‘‘cost benefit’’ OR ‘‘cost benefits’’ OR ‘‘cost
analys*’’ OR ‘‘cost assessment’’ OR ‘‘cost effectiveness’’ OR ‘‘cost utility’’ OR ‘‘cost utilities’’ OR profit* OR ‘‘cost allocation’’ OR ‘‘cost
benefit analys*’’ OR ‘‘cost control’’ OR ‘‘cost controls’’ OR ‘‘cost saving’’ OR ‘‘cost savings’’ OR ‘‘costs savings’’ OR ‘‘cost of illness’’ OR
‘‘costs of illness’’ OR ‘‘cost of disease’’ OR ‘‘costs of disease’’ OR ‘‘cost of intervention’’ OR ‘‘costs of intervention’’ OR ‘‘cost sharing’’
OR ‘‘costs sharing’’ OR ‘‘health care cost’’ OR ‘‘health care costs’’ OR ‘‘health care expenditure’’ OR ‘‘health care expenditures’’ OR
‘‘value of life’’ OR ‘‘societal benefit*’’ OR ‘‘economic evaluation’’ OR ‘‘economic analys*’’ OR ‘‘economic assessment’’ OR ‘‘health
economics’’ OR ‘‘resource allocation’’ OR ‘‘cost avoidance’’ OR ‘‘costs avoidance’’ OR ‘‘loss avoidance’’ OR ‘‘losses avoidance’’)
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when a number are available. These studies also emphasize
the importance of environmental interventions, such as
vector control, improved sanitation and hygiene, and
integrated surveillance programs, to control the human
impact of such diseases (World Health Organization 2014).
Increased trade and globalization, together with climate
change, habitat encroachment, and forest fragmentation,
have augmented the possibility of vector-borne disease
transmission (Sherman 2010), and this was exemplified by
the recent emergence of Chikungunya and Zika virus in
Table 2. An Overview of the Type and Value of Quantitative Outcomes Featuring in Those Studies that Described One Health
Interventions to Address Rabies Included in this Scoping Review.
References Geographical
location
Intervention Type of quantitative
outcome described
Outcome reported
Dogs
Bo¨gel and Meslin (1990) Developing
countries
Combined dog vaccination
and human PEPa
Cost efficiency Cost-efficient in 5 years
Fishbein et al. (1991) Philippines One-year dog vaccination
campaign
Time to recoup costs 4.1–11.0 years
Fitzpatrick et al. (2014) Tanzania Annual dog vaccination
campaigns (at different
vaccination coverage)
Number of deaths averted 0.6–2.0
Percentage of deaths averted 8.3–39.3%
Cost-effectiveness Cost-effective to very
cost-effective
Ha¨sler et al. (2014b) Sri Lanka Dog vaccination and other
control interventions
DALYsb averted 738
Animal welfare impact score Improved
Program costs US$ 1.03 million
Pinto et al. (2011) Brazil Dog vaccination (vs. human
PEPa)
Cost comparison Costs 9.2–20.2 lower (in
Brazilian Real)
Tenzin and Ward (2012) Bhutan Combined dog vaccination
and human PEPa (vs.
human PEPa only)
Cost savings US$ 0.09 million saved
after 6 years
Townsend et al. (2013) Bali Comprehensive high
coverage dog vaccination
Human lives saved over 10 years 550
Money saved over 10 years US$ 15 million
Zinsstag et al. (2009) Chad One-year dog vaccination
campaign
Cost per death averted US$ 596
by 10th year
Time to recoup costs 5.9 years
Wildlife
Aubert (1999) France Wildlife vaccination (vs. fox
depopulation)
Cost–benefit analysis Beneficial after 4th year
Ministe`re de la Sante´ et de la
Protection Sociale
Franc¸aise (1989)
France Evaluation of oral
vaccination programs
in wildlife
Cost–benefit analysis Beneficial in 10–12 years
(less for some
departments)
Shwiff et al. (2011) Canada Rabies control program
including fox vaccination
Benefit–cost ratio 0.49–1.36
Cost savings US$ 35.48–98.41 million
Shwiff et al. (2012) Canada Rabies control programs
including raccoon
vaccination
Benefit–cost ratio 0.96–1.55
Cost savings US$ 46.70–52.93 million
Uhaa et al. (1992) USA Administration of oral
vaccines to raccoons
Benefit–cost ratio 2.21–6.80
Cost savings US $1.95 million
aPEP post-exposure prophylaxis.
bDALYs disability-adjusted life years.
L. C. Falzon et al.
Latin America and the Caribbean (World Health Organi-
zation 2016a). Cross-sectorial approaches identified in this
review could therefore set an example for future endeavors
focusing on emerging vector-borne diseases. Ultimately it
appears that the magnitude of benefit and the timescale
over which control programs must be in place for the
realization of benefit is disease and environment depen-
dent. There is value in policy-makers identifying diseases
and contexts similar to their own within this review to use
as framework for designing programs specific to their own
situations.
While the top biotic health issues described in our
included studies may reflect funding priorities, they also
mirror to a large extent recent findings on the global bur-
den of disease (GBD). Infectious diseases such as rabies,
malaria, and dengue are ranked among the top six WHO
parasitic and vector-borne diseases (World Health Orga-
nization 2016b), and among the top ten NTD by the Lancet
(Global Burden Disease 2015 DALYs and HALE Collabo-
rators, 2016). Similarly, among all food-borne hazards,
campylobacteriosis and salmonellosis, together with en-
teropathogenic Escherichia coli, were found to be the most
relevant contributors to DALYs (World Health Organiza-
tion Global Burden of Foodborne Diseases 2015). Notice-
ably, other zoonotic diseases with a high GBD, such as
leishmaniasis or schistosomiasis, rarely featured in our
findings. Reasons for this might be either that the OH
interventions have not yet been used for their control, or
that the study outcome was not assessed in a quantitative
manner or it could not be attributed clearly to the OH
intervention. Recent guidelines for OH studies, which also
encourage authors to mention how they think the OH
approach added value to the study, should help by clari-
fying whether a OH approach was used in the study and
how it contributed to the final outcome (Davis et al. 2017).
In our review, abiotic health issues, such as respiratory
disease due to air pollution or metal intoxication, were only
described in 16.5% of the included studies. The importance
Table 3. An Overview of the Type and Value of Quantitative Outcomes Featured in Those Studies that Described One Health
Interventions to Address Salmonellosis Included in this Scoping Review.
References Geographical
location
Intervention Type of quantitative
outcome described
Outcome reported
Goldbach and Alban
(2006)
Denmark Hot water decontamination
of pig carcasses
Net present value 3.5 million Euro over
15 years
Kangas et al. (2007) Finland Salmonella control
policies in broiler
production
Benefit–cost ratio 0.04–21.25
Korsgaard et al.
(2009)
Denmark Salmonella control
programs in egg
production
Number of human
cases averted
10,200 (95% CI:
8100–12,400)
Societal costs saved 23.3 million Euro (95%
CI: 16.3– 34.9)
Cost–benefit ratio 0.5
Miller et al. (2005) USA Pig vaccination Reduction in human
cases
60%
Benefit–cost ratio Less than 1
Pig carcass rinsing at
various water
temperatures
Benefit–cost ratio Greater than 1
Persson and Jendteg
(1992)
England, Wales
and Sweden
Use of competitive
exclusion in poultry
production
Costs of illness saved Up to 12.6 million GBP
Romero-Barrios et al.
(2013)
European
Union
Interventions on pig farms
and during pig slaughter
Risk reduction Up to 90% risk reduction
Wegener et al. (2003) Denmark Salmonella control
programs in pig and
poultry production
Costs saved US $25.5 million
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of considering the environmental component of public
health was recently reiterated in the Hanoi Declaration
(Hanoi Declaration 2015) and subsequent Sustainable
Development Goals [particularly non-communicable con-
ditions such as cardiac disease, cancer, and obesity (United
Nations 2015)]. Therefore, these cross-sectorial studies that
tackle abiotic health issues, such as the impact of air and
water pollution on human health, bring to light opportu-
nities and avenues for a collaborative OH approach which
need not be limited to communicable diseases. Two studies
included in this review investigated the positive health
benefits accrued through dog walking (Bauman et al. 2001;
Kushner et al. 2006). Dog ownership encourages owner
physical activity and has been described as a cost-effective
and socially acceptable preventive measure for the current
obesity epidemic (Mills and Hall 2014). This highlights the
opportunity for improved disease prevention and control
through OH approaches, by investigating the pivotal hu-
Table 4. An Overview of the Type and Value of Quantitative Outcomes Featured in Those Studies that Described One Health
Interventions to Address Campylobacteriosis Included in this Scoping Review.
References Geographical
location
Intervention Type of quantitative
outcome described
Outcome reported
Gellynck et al.
(2008)
Belgium Decontamination of poultry
carcasses with electrolyzed
oxidizing water
Cost–benefit ratio 17.66
Decontamination of poultry
carcasses with lactic acid
4.06
Phage therapy used on
chicken farms
2.54
Havelaar et al.
(2007)
The Netherlands Strict hygienic measures on
chicken farms
Cost-effectiveness based
on a cost–utility
ratioa  Euro
50,000/DALYsb
Cost-effective
Reduced fecal leakage during
carcass processing
Cost-effective
Chemical decontamination of
poultry carcasses
Cost-effective
Jensen and Jensen
(2013)
European Union Vaccination of chicks Cost neutralization 1.65 Euro per
vaccine dose
Lake et al. (2013) New Zealand Poultry slaughterhouse
improvements (e.g., new
evisceration machines)
Cost per DALYsb saved NZ$ 1200
Continuous chemical
treatment of poultry carcass
NZ$ 1700
Phage-based controls on
chicken farms
NZ$ 3000
Mangen et al.
(2007)
The Netherlands Phage therapy used on
chicken farms
Cost-effectiveness based
on a cost–utility
ratioa  100,000 Euro/
DALYsb
Cost-effective
Romero-Barrios
et al. (2013)
European Union Application of fly screens in
indoor poultry flocks
Risk reduction 60%
Treating or freezing broiler
carcasses
87–98%
aCost–utility ratio is described as the ratio of the net cost of intervention to averted disease burden in DALYs.
bDALYs disability-adjusted life years.
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Table 5. An Overview of the Type and Value of Quantitative Outcomes Featuring in Those Studies that Described One Health
Interventions to Address Malaria Included in this Scoping Review.
References Geographical
location
Intervention Type of quantitative
outcome described
Outcome reported
Aikins et al. (1998) Gambia Use of ITNa Cost-effectiveness per death
averted
US$ 471
Cost-effectiveness per
discounted life years gained
US$ 31.53
Akhavan et al. (1999) Brazil National malaria control
program including
vector control
Cost-effectiveness per life
saved
US$ 2672
Cost-effectiveness per
DALYsb averted
US$ 69
Gatton and Cheng
(2010)
Australia ITNa and chemotherapy Disease transmission No transmission
possible
Goodman et al.
(1999)
Low-income country
in sub-Saharan
Africa
Provision of bed nets Cost-effectiveness per
DALYsb averted
US$ 19–85
Insecticide treatment of
existing bed nets
US$ 4–10
Goodman et al.
(2001)
South Africa ITNa (vs. residual house
spraying)
Effectiveness (adjusted rate
ratio based on number of
cases)
0.69
Cost per case averted US$ 16
Cost per death averted US$ 1696
Mueller et al. (2008) Togo Three-year ITNa
campaign
Number of deaths averted 6285
Number of cases averted 1.2 million
Cost per death averted US$ 635
Cost per DALYsb averted US$ 16.39
Mulligan et al.
(2008)
Tanzania ITNa voucher program Number of child deaths
averted
12,039
Cost per child death averted US$ 873
Pulkki-Bra¨nnstro¨m
et al. (2012)
Not specified Long-lasting ITNa (vs.
conventional ITNa)
Child deaths averted 30,800
DALYsb averted 1.02 million
Cost per DALYsb averted US$ 16.8
Cost-effectiveness Cost-effective if
priced at no
more than US$
1.5 above
conventional
ITNa
Riedel et al. (2010) Zambia Bed nets Odds of parasitaemia 40% less (12–60%)
Smithuis et al. (2013) Myanmar ITNa (vs. early diagnosis
and effective treatment)
Cost per DALYsb averted US$ 51
Yhdego and Majura
(1988)
Tanzania Comparison of two vector
control programs:
engineering vs. use of
larvicides and
insecticides
Program effectiveness 97 vs. 75%
Cost-effectiveness Tshs 2.8 million vs.
Tshs 10.5 million
aITN insecticide-treated bed nets.
bDALYs disability-adjusted life years.
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man–animal companionship relationship to combat not
only obesity, but also depression and cognitive disorders.
Antimicrobial resistance (AMR) did not feature in any
of our included studies. This was surprising given both the
attention it has received in recent years, and its complex
and multifaceted nature which makes it amenable to cross-
sectorial approaches (Queenan et al. 2016; Singh 2017;
World Health Organization 2017). Since our literature
search was conducted in 2014, it is likely the more recent
focus on AMR in published research in the last few years
would not have been captured. Similarly, we may have
missed studies that describe a OH approach when dealing
with other health issues, such as salmonellosis and try-
panosomiasis, but were published after our final literature
search was conducted (Sundstro¨m et al. 2014; Shaw et al.
2015).
The majority of the 85 studies included for qualitative
synthesis were performed after 2000. This is not surprising
as the OH initiative has been gaining momentum over the
past decade, and the amount of interdisciplinary research
has been shown to be increasing (Sta¨rk et al. 2015; Van
Noorden 2015). Nonetheless, segregation between disci-
plines still persists, particularly between the veterinary and
ecological sciences (Manlove et al. 2016), and future
interdisciplinary studies should ensure that the ecosystem
component is properly represented (Barrett and Bouley
2015). Most identified studies described modeling ap-
proaches, either as mathematical modeling of infectious
diseases or economic analyses. We realize that this may
have been biased both by our search terms which targeted
such studies and by our inclusion criteria which selected
only for those studies that had a quantitative outcome.
Table 6. An Overview of the Type and Value of Quantitative Outcomes Featured in Those Studies that Described One Health
Interventions to Address Dengue Included in this Scoping Review.
References Geographical
location
Intervention Quantitative outcome
described
Values reported
Dı´az (2012) Cuba Integrated surveillance
system
Detection of febrile cases Increased
McConnell and
Gubler (2003)
Puerto Rico Control of vector
breeding sites
Cost-effectiveness Cost-effective if dengue
transmission is reduced
by 50% and intervention
costs less than US$ 2.50
per person
Ocampoa et al.
(2014)
Colombia Identification and
spraying of vector
breeding sites
Rate ratio of human
incidence
0.19 (95% CI 0.12–0.30)
compared to control
area
Orellano and Ped-
roni (2008)
Argentina Fumigation of vectors Net present value I$ 196,879
Cost–benefit analysis Beneficial when more than
1363 cases of dengue
and at least 1 case of
dengue hemorrhagic
fever are averted
Suaya et al. (2007) Cambodia Annual targeted larvicidal
campaigns
Cost per DALYsa saved
(public perspective)
US$ 313
Cost per DALYsa saved
(societal perspective)
US$ 37
Tsunoda et al.
(2013)
Vietnam Use of insecticide-treated
nets to cover water
reservoirs
Human seroprevalence 62.2% (vs. 74.6% in
control area)
Addition of insecticide to
other water containers
aDALYs disability-adjusted life years.
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However, we think that this could also be partly due to the
fact that some of the topics addressed may be hard to
implement in the field given their underlying complexity.
Moreover, funding for such interdisciplinary endeavors
may be hard to obtain, thus making modeling approaches a
more feasible and economically viable option.
One of the greatest challenges of this review lay with the
definition of OH. The definition provided by the American
Veterinary Medical Association (2008) was chosen to inform
the review, and several examples were provided within the
screening forms to ensure consistency in the interpretation of
OH. Despite this, the interpretation of some references was
difficult. Therefore, it is possible that studies may have been
excluded which according to other definitions may be con-
sidered OH or, conversely, included studies which may not
be considered OH. The recently published COHERE
checklist for OH studies (Davis et al. 2017) should help with
such future endeavors by setting a benchmark as to what
should be considered a OH approach.
The final list of studies only included around 0.0025%
of all screened references. This was expected given the
broad search terms used. It was agreed that given the
objective to identify those studies that described a OH
approach (without necessarily containing the term OH),
the sensitivity of the search should be prioritized over the
specificity. Despite the broad search terms, a certain pub-
lication bias is to be expected based on the selection of
literature databases, although they were selected pertinent
to the type of studies that were sought in the review. An
information specialist who specializes in objective, struc-
tured reviews of the literature (DG) was consulted and
involved in the process of this review to ensure that the
most appropriate databases were searched. Furthermore,
we attempted to identify relevant studies in the gray liter-
ature through our search verification, which included ex-
pert elicitation and review of relevant textbooks. Future
work should prioritize investigating these alternative
sources further, as it is possible that the expected positive
publication bias could have affected the results obtained.
As our review question focused on quantitative out-
comes, we excluded those studies which described quali-
tative outcomes of a OH approach, such as improved
knowledge on health topics, changes in attitude or prac-
tices, or improved participation, which are a necessary
preceding step to ensure uptake and implementation of
interventions and practices (World Health Organization
2014). These outcomes may be harder to evaluate as they
are often intangible and incommensurable. Yet they are
important components of the overall societal benefit and
should therefore be taken into consideration when making
decisions regarding fund allocation for disease control
programs or other interventions.
We note that during the full-text screening process we
excluded 60 references which described a OH approach but
not a quantitative outcome. This lack of reported outcomes is
similar to findings reported by other recently published re-
views (Ha¨sler et al. 2014a; Baum et al. 2017) and underlines a
gap in current published research, where missing quantifi-
cation of the evidence may hinder the uptake of research
findings. Additionally, while this review identified a
numerous diversity of monetary and non-monetary terms,
this diversity in itself may impede comparisons between
studies. We therefore encourage harmonization of metrics to
ensure that future research is both outcome-based and
comparable, thus facilitating interpretation and implemen-
tation of findings based on OH approaches. It is important
for a number of stakeholders to be involved in the decision-
making process in relation to the prioritization of which
outcomes should be consistently measured in studies
employing a OH approach. All levels of decision-makers
should be included in the process, from those in the field to
those at the policy-making level. This will ensure that the
most appropriate outcomes, and therefore the most likely to
be successfully captured, are identified. It is suggested that
structured objective frameworks such as the Delphi
methodology (Okoli and Pawlowski 2004) and those em-
ployed by the James Lind Alliance (http://www.jla.nihr.ac.
uk/) be utilized for this purpose.
This review identifies a number of studies that may not
have included terminology relating to OH but have em-
ployed a OH approach. Additionally, this is the first time that
the quantitative outcomes of OH studies have been collec-
tively reported, and therefore could provide an additional
resource for policy-makers to utilize for similar OH research
studies in the future. Future work should focus on investi-
gating further the gray literature for other similar studies and
the harmonization of metrics employed to determine the
success of approaches across all OH studies.
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